Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries
Background. Through its normative and public health leadership roles, the World Health Organization (WHO) plays a key role in the availability of vaccine products in low-and middle-income countries. The recent introduction of a new group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in Afr...
Main Authors: | Dellepiane, Nora, Akanmori, Bartholomew Dicky, Gairola, Sunil, Jadhav, Suresh S., Parker, Cathy, Rodriguez, Carmen, Srivastava, Swati |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639481/ |
Similar Items
-
Meningococcal carriage in the African meningitis belt
Published: (2013) -
The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
Published: (2015) -
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
by: Lingani, Clément, et al.
Published: (2015) -
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt
by: Manigart, Olivier, et al.
Published: (2016) -
Incidence, Carriage and Case-Carrier Ratios for Meningococcal Meningitis in the African Meningitis Belt: A Systematic Review and Meta-Analysis
by: Koutangni, Thibaut, et al.
Published: (2015)